Actemra 160mg, a treatment known scientifically as tocilizumab, functions as a potent pharmaceutical agent primarily employed for the control of rheumatoid arthritis. This powerful substance acts by inhibiting the activity of interleukin-6 (IL-6), a communication protein vital in the inflammatory process. Furthermore, Actemra exhibits efficacy in